EMVision Medical Devices Ltd (ASX:EMV)
Australia · Delayed Price · Currency is AUD 1.670
-0.055 (-3.19%)
Aug 28, 2026, 4:10 PM AEST
EMVision Medical Devices Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 8.27 | 4.89 | 11.15 | 6.96 | 4 |
Other Revenue | 0.57 | 0.16 | 0.07 | 0.02 | 0.36 |
| 8.85 | 5.05 | 11.22 | 6.97 | 4.36 | |
Revenue Growth | 75.17% | -54.97% | 60.89% | 59.92% | 156.66% |
Gross Profit | 8.85 | 5.05 | 11.22 | 6.97 | 4.36 |
Selling, General & Admin | 9.91 | 8.57 | 7.26 | 6.45 | 5.86 |
Research & Development | 4.96 | 4.04 | 4.7 | 2.01 | 2.33 |
Other Operating Expenses | - | 0.31 | 0.23 | 0.21 | 0.16 |
Operating Expenses | 16.93 | 13.9 | 13.48 | 10.93 | 10.47 |
Operating Income | -8.08 | -8.84 | -2.26 | -3.96 | -6.11 |
Interest Expense | -0.2 | -0.09 | -0.12 | -0.04 | -0.02 |
Interest & Investment Income | - | 0.58 | 0.34 | 0.12 | 0.02 |
EBT Excluding Unusual Items | -8.28 | -8.36 | -2.03 | -3.87 | -6.11 |
Pretax Income | -8.28 | -8.36 | -2.03 | -3.87 | -6.11 |
Income Tax Expense | 0.03 | 1.45 | 0.7 | - | - |
Net Income | -8.32 | -9.81 | -2.73 | -3.87 | -6.11 |
Net Income to Common | -8.32 | -9.81 | -2.73 | -3.87 | -6.11 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 91 | 85 | 80 | 78 | 75 |
Shares Outstanding (Diluted) | 91 | 85 | 80 | 78 | 75 |
Shares Change | 6.61% | 6.22% | 3.51% | 3.35% | 7.27% |
EPS (Basic) | -0.09 | -0.11 | -0.03 | -0.05 | -0.08 |
EPS (Diluted) | -0.09 | -0.11 | -0.03 | -0.05 | -0.08 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -6.37 | -7.89 | -6.11 | 0.65 | -3.97 |
Free Cash Flow Per Share | -0.07 | -0.09 | -0.08 | 0.01 | -0.05 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -91.33% | -175.06% | -20.12% | -56.72% | -140.05% |
Profit Margin | -93.98% | -194.10% | -24.33% | -55.51% | -140.11% |
Free Cash Flow Margin | -71.99% | -156.11% | -54.43% | 9.28% | -91.12% |
EBITDA | -7.98 | -8.71 | -2.09 | -3.83 | -6.03 |
EBITDA Margin | -90.15% | -172.44% | -18.64% | -54.90% | -138.34% |
D&A For EBITDA | 0.1 | 0.13 | 0.17 | 0.13 | 0.07 |
EBIT | -8.08 | -8.84 | -2.26 | -3.96 | -6.11 |
EBIT Margin | -91.33% | -175.06% | -20.12% | -56.72% | -140.05% |
Revenue as Reported | 8.85 | 5.63 | 11.56 | 7.09 | 4.38 |